Trade Deal Boosts Stocks, but Drug Makers Face Pressure

US markets rise as optimism from a new trade deal ignites gains. However, pressure builds on drug makers following proposed cost cuts. Earnings forecasts are mixed, raising concerns for investors.

Date: 10-05-2025

AI Rating: 7

Market Overview
The recent report highlights significant movements in the stock market, spurred largely by President Trump's announcement of a new trade deal with the UK. The announcement fosters optimism around easing tariffs, which may prevent negative impacts on economic growth and corporate profitability.

Earnings Per Share (EPS)
Noteworthy is the performance of EPAM Systems, achieving a Q1 adjusted EPS of $2.41 compared to the consensus estimate of $2.27, prompting a raised full-year forecast. This signals strong fundamentals in the tech sector, particularly in software and IT services, which may attract investor interest.

Revenue Growth
Carvana's reported Q1 revenue of $4.23 billion exceeded estimates by 7%, showcasing the company's operational resilience. Similarly, AppLovin's Q1 revenue of $1.48 billion has outperformed expectations, indicating solid performance in the tech space amidst fluctuating market conditions. The anticipated earnings growth of +6.7% for the S&P 500 for Q1 highlights a generally healthy growth trajectory.

Pressure on Drug Makers
Conversely, the drug and pharmaceutical sector faces challenges as proposed measures to cut drug prices could erode margins. This could negatively impact companies like Regeneron, Eli Lilly, and Merck, all facing stock pressure due to government intervention fears, influencing investor sentiment in the sector.

Labor Market and Productivity
The report’s mention of rising unit labor costs (+5.7%) may indicate rising operating costs for companies, which could pressure profit margins going forward. Furthermore, the first decline in non-farm productivity in nearly three years raises concerns over efficiency and economic growth.

Interest Rates and Bond Yields
Notably, the market is dismissing the likelihood of a significant interest rate cut following robust initial job claims data and rising labor costs, reflecting a hawkish stance that could limit stock market upside in the near term. Increased bond yields today correlate with the stronger labor data, suggesting potential headwinds for equity valuations.

In summary, while certain sectors, particularly tech, are thriving, headwinds from proposed regulatory changes, labor costs, and productivity concerns may present challenges for investors. The dynamics are poised to influence stock valuations across industries markedly.

Stocks: AMD MRVL INTC MCHP OXY DVN MPC COIN MSTR MARA RIOT EPAM APP REGN LLY GILD ABBV VRTX AMGN MRK BMY FTNT MTCH ARM TAP G